MediGene Applies Evotec OAI`s Leading Technologies for the Identification Of Novel Drugs to Treat Cardiovascular Diseases
(PR Newswire)...the drug Etomoxir to treat congestive heart failure is in phase 2, G207 to treat brain cancers successfully completed phase 1 and is preparing for phase 2 trials,......For the development and the marketing of this vaccine as well as one additional tumor vaccine, strategic product alliances with Schering and Aventis Pharma have been concluded....- Mar 28 6:02 AM ET
IF the story does not appear below, Click HERE to view the text of the story!
Note: The original website is displayed below - we have no control over it and are not responsible for the content of it, we just report it! IF you click on anything below, it will take you off of our website!
Original Source: http://biz.yahoo.com/prnews/010328/lnw007.html
(Everything below this line is from VirtualTrials.com!)
Click HERE to return to brain tumor news headlines